Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study

Overview of attention for article published in PLOS ONE, March 2013

Altmetric Badge

Mentioned by

blogs: 1 blog

patent: 1 patent

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 40 Mendeley

Summary Blogs Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Methods and compositions for prevention or treatment of a disease

Grant US-9574211-B2

United States of America